Literature DB >> 30382360

A prognostic index for colorectal cancer based on preoperative absolute lymphocyte, monocyte, and neutrophil counts.

Akimitsu Tanio1, Hiroaki Saito2, Chihiro Uejima1, Seigo Takaya1, Manabu Yamamoto1, Naruo Tokuyasu1, Teruhisa Sakamoto1, Soichiro Honjo1, Keigo Ashida1, Yoshiyuki Fujiwara1.   

Abstract

PURPOSE: Associations between the preoperative absolute neutrophil count (NC), lymphocyte count (LC), and monocyte count (MC) in the peripheral blood and the prognosis of colorectal cancer (CRC) patients have not been widely studied.
METHODS: We enrolled 361 patients who underwent surgery for CRC between January 2007 and December 2013 to analyze correlations among the LC, MC, and NC and prognosis.
RESULTS: Based on cut-off values determined by a receiver operating characteristic analysis, patients were subgrouped as LymphHigh or LymphLow (cut-off: LC = 1460 cells/µL); as MonoHigh or MonoLow (cut-off: MC = 421 cells/µL); and as NeutHigh or NeutLow (cut-off: NC = 3247 cells/µL). Patients were then given lymphocyte-monocyte-neutrophil (LMN) scores by adding the points of their different subgroups (1 point each for LymphLow, MonoHigh and NeutHigh; 0 points for LymphHigh, MonoLow and NeutLow). The 5-year overall survival rates significantly differed by the LMN score (0: 89.7%, 1: 80.6%, 2: 68.8%, and 3: 57.4%; P < 0.0001). In the multivariate analysis, the LMN score was found to be an independent prognostic indicator.
CONCLUSIONS: The combination of the preoperative absolute number of lymphocytes, monocytes, and neutrophils is a useful prognostic indicator in CRC patients.

Entities:  

Keywords:  Colorectal cancer; Lymphocyte; Monocyte; Neutrophil; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 30382360     DOI: 10.1007/s00595-018-1728-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  miRNA Expression Profile in the N2 Phenotype Neutrophils of Colorectal Cancer and Screen of Putative Key miRNAs.

Authors:  Liang Wang; Jun Yang; Jian Huang; Zheng-Qi Wen; Ning Xu; Xuan Liu; Jian-Hua Zhang; Wen-Liang Li
Journal:  Cancer Manag Res       Date:  2020-07-07       Impact factor: 3.989

2.  Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer.

Authors:  Manabu Yamamoto; Hiroaki Saito; Kazushi Hara; Ken Sugezawa; Chihiro Uejima; Akimitsu Tanio; Yoichiro Tada; Kyoichi Kihara; Teruhisa Sakamoto; Soichiro Honjo; Yoshiyuki Fujiwara
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

3.  Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.

Authors:  Xinxin Li; Dongming Guo; Lingyu Chu; Yiteng Huang; Feiran Zhang; Wei Li; Juntian Chen
Journal:  Cancer Manag Res       Date:  2019-11-14       Impact factor: 3.989

4.  Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.

Authors:  Shu Wen; Nan Chen; Ying Hu; Litao Huang; Jin Peng; Meina Yang; Xiaoyang Shen; Yang Song; Liangzhi Xu
Journal:  Cancer Med       Date:  2021-02-16       Impact factor: 4.452

5.  Preoperative low absolute lymphocyte count to fibrinogen ratio correlated with poor survival in nonmetastatic colorectal cancer.

Authors:  Xiang Huang; Yu Huan; Long Liu; Qianwen Ye; Jian Guo; Bing Yan
Journal:  World J Surg Oncol       Date:  2022-09-24       Impact factor: 3.253

6.  Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.

Authors:  Dongming Guo; Xinxin Li; Aosi Xie; Qiangjian Cao; Jinhai Zhang; Feiran Zhang; Wei Li; Juntian Chen
Journal:  J Clin Lab Anal       Date:  2019-11-21       Impact factor: 2.352

7.  Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics.

Authors:  Peiyun Long; Youya Zang; Huan Wang; Xiumei Liang; Xuekun Xie; Zhiwei Han; Dongyi Lin; Zongyu Wang; Shan Huang; Chuang Chen
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.